Skip to main content
Beat Cancer EU Website Logo
Empowering Young Warriors: Das EJP RD Paediatric Expert Patients Training für die Erforschung und den Einsatz für seltene Krankheiten
PolitikAlleRelated Projects

Empowering Young Warriors: Das EJP RD Paediatric Expert Patients Training für die Erforschung und den Einsatz für seltene Krankheiten

Europäisches gemeinsames Programm für seltene Krankheiten - Schaffung eines Ökosystems für die Erforschung seltener Krankheiten im Dienste des Fortschritts, der Innovation und des Nutzens für alle

Jahr:2019

The European Joint Programme on Rare Diseases (EJP RD) is a programme aiming to create an effective rare diseases research ecosystem for progress, innovation and for the benefit of everyone with a rare disease. The programme supports rare diseases stakeholders by funding research, bringing together data resources & tools, providing dedicated training courses, and translating high quality research into effective treatments.

The Paediatric Expert Patients Training under the EJP RD provides young rare disease patients with skills enabling them to get involved in clinical research. The activities include short workshops under the coordination of the TEDDY European Network of Excellence for Paediatric Research in collaboration with EURORDIS and the Sant Joan de Déu Research Foundation for 15 paediatric patients focusing on the following areas:

• Genetic /rare disease characteristics and evolution;
• Role for paediatric patients and relevance of clinical and translational research (including patients’ engagement in clinical trials, the consent issue, the patient-reported outcomes in the context of paediatric rare diseases, data protection and children rights);
• Orphan Medicinal Products availability and access for paediatric patients on the EU market, pharmacovigilance and off-label use in paediatric setting.

Diskussion & Fragen

Hinweis: Kommentare dienen nur zur Diskussion und Klärung. Für medizinischen Rat wenden Sie sich bitte an eine medizinische Fachkraft.

Kommentar hinterlassen

Mindestens 10 Zeichen, maximal 2000 Zeichen

Noch keine Kommentare

Seien Sie der Erste, der seine Gedanken teilt!